Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02414347

F 18 T807 Tau PET Imaging of Alzheimer's Disease

Sponsor: Tammie L. S. Benzinger, MD, PhD

View on ClinicalTrials.gov

Summary

A single-center, open-label baseline controlled imaging study designed to assess whether brain tau fibril uptake of flortaucipir as measured by PET correlates with cognitive status of individuals with and without brain tau fibrils.

Official title: F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

900

Start Date

2014-10-23

Completion Date

2024-12

Last Updated

2024-07-17

Healthy Volunteers

No

Interventions

DRUG

F 18 T807

Participants will receive a single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807. For those who cannot tolerate the full exam, participants will receive single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807.

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States